 |
PDBsum entry 2k11
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Solution structure of human pancreatic ribonuclease
|
|
Structure:
|
 |
Pancreatic ribonuclease. Chain: a. Synonym: rnase 1, rnase a, rnase upi-1, rib-1, hp-rnase. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Gene: rnase1, rib1, rns1. Expressed in: escherichia coli.
|
|
NMR struc:
|
 |
20 models
|
 |
|
Authors:
|
 |
K.E.Kover,M.Bruix,J.Santoro,G.Batta,D.V.Laurents,M.Rico
|
Key ref:
|
 |
K.E.Kövér
et al.
(2008).
The solution structure and dynamics of human pancreatic ribonuclease determined by NMR spectroscopy provide insight into its remarkable biological activities and inhibition.
J Mol Biol,
379,
953-965.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-Feb-08
|
Release date:
|
03-Jun-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P07998
(RNAS1_HUMAN) -
Ribonuclease pancreatic from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
156 a.a.
127 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.4.6.1.18
- pancreatic ribonuclease.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
an [RNA] containing cytidine + H2O = an [RNA]-3'-cytidine- 3'-phosphate + a 5'-hydroxy-ribonucleotide-3'-[RNA]
|
|
2.
|
an [RNA] containing uridine + H2O = an [RNA]-3'-uridine-3'-phosphate + a 5'-hydroxy-ribonucleotide-3'-[RNA]
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
379:953-965
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
The solution structure and dynamics of human pancreatic ribonuclease determined by NMR spectroscopy provide insight into its remarkable biological activities and inhibition.
|
|
K.E.Kövér,
M.Bruix,
J.Santoro,
G.Batta,
D.V.Laurents,
M.Rico.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human pancreatic ribonuclease (RNase 1) is expressed in many tissues; has
several important enzymatic and biological activities, including efficient
cleavage of single-stranded RNA, double-stranded RNA and double-stranded RNA-DNA
hybrids, digestion of dietary RNA, regulation of vascular homeostasis,
inactivation of the HIV, activation of immature dendritic cells and induction of
cytokine production; and furthermore shows potential as an anti-tumor agent. The
solution structure and dynamics of uncomplexed, wild-type RNase 1 have been
determined by NMR spectroscopy methods to better understand these activities.
The family of 20 structures determined on the basis of 6115 unambiguous nuclear
Overhauser enhancements is well resolved (pairwise backbone RMSD=1.07 A) and has
the classic RNase A type of tertiary structure. Important structural differences
compared with previously determined crystal structures of RNase 1 variants or
inhibitor-bound complexes are observed in the conformation of loop regions and
side chains implicated in the enzymatic as well as biological activities and
binding to the cytoplasmic RNase inhibitor. Multiple side chain conformations
observed for key surface residues are proposed to be crucial for membrane
binding as well as translocation and efficient RNA hydrolysis. (15)N-(1)H
relaxation measurements interpreted with the standard and our extended
Lipari-Szabo formalism reveal rigid regions and identify more dynamic loop
regions. Some of the most dynamic areas are key for binding to the cytoplasmic
RNase inhibitor. This finding and the important differences observed between the
structure in solution and that bound to the inhibitor are indications that RNase
1 to inhibitor binding can be better described by the "induced fit" model rather
than the rigid "lock-into-key" mechanism. Translational diffusion measurements
reveal that RNase 1 is predominantly dimeric above 1 mM concentration; the
possible implications of this dimeric state for the remarkable biological
properties of RNase 1 are discussed.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Representative relaxation data for amide groups of
Arg4 (helix α[1]), Val57 (helix α[3]), Gly70 (loop), Met79
(strand β[4]) and Ser127 (C-terminus). (a) T[1] and (b) T[2]
values. Lines represent the fits of an exponential decay
function to these data sets.
|
 |
Figure 6.
Fig. 6. Distribution of (a) ^15N CSA values and of (b) HN/CSA
axis angles along the RNase 1 sequence.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2008,
379,
953-965)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Kuzmanic,
and
B.Zagrovic
(2010).
Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors.
|
| |
Biophys J,
98,
861-871.
|
 |
|
|
|
|
 |
A.Merlino,
G.Avella,
S.Di Gaetano,
A.Arciello,
R.Piccoli,
L.Mazzarella,
and
F.Sica
(2009).
Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant.
|
| |
Protein Sci,
18,
50-57.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.V.Laurents,
M.Bruix,
M.A.Jiménez,
J.Santoro,
E.Boix,
M.Moussaoui,
M.V.Nogués,
and
M.Rico
(2009).
The (1)H, (13)C, (15)N resonance assignment, solution structure, and residue level stability of eosinophil cationic protein/RNase 3 determined by NMR spectroscopy.
|
| |
Biopolymers,
91,
1018-1028.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Batta,
T.Barna,
Z.Gáspári,
S.Sándor,
K.E.Kövér,
U.Binder,
B.Sarg,
L.Kaiserer,
A.K.Chhillar,
A.Eigentler,
E.Leiter,
N.Hegedüs,
I.Pócsi,
H.Lindner,
and
F.Marx
(2009).
Functional aspects of the solution structure and dynamics of PAF--a highly-stable antifungal protein from Penicillium chrysogenum.
|
| |
FEBS J,
276,
2875-2890.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |